Slideshow
Author(s):
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
NeurologyLive® Friday 5 — March 14, 2025
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging
Neurology Unwrapped: 2024’s Most Intriguing Conversations
FDA Action Update, February 2025: Approvals, Designations, and Acceptances
NeurologyLive® Brain Games: March 9, 2025